Target intelligence / Profile preview

Regulatory T lymphocyte cell population in intestine (Treg cell (intestinal), Foxp3+ Treg cell)

Target
Treg cell (intestinal), Foxp3+ Treg cell
Molecular classification
Other (immune cell subset)
01

Overview

Regulatory T lymphocytes in the intestine—commonly called intestinal regulatory T cells or gut-resident Foxp3+ regulatory T cells—are a specialized subpopulation of CD4+ helper lymphocytes that play essential roles in maintaining immune homeostasis within the gastrointestinal tract. They actively suppress inappropriate immune responses against harmless dietary antigens and commensal microorganisms while also contributing non-immunological functions such as promoting tissue repair and preserving epithelial barrier integrity. Key mechanisms include secretion of anti-inflammatory cytokines like interleukin‑10, expression of CTLA‑4 which inhibits co-stimulation on effector cells, suppression of Th17-mediated inflammation via RORγt-expressing subsets, and adaptation to local microenvironmental cues including signals from diet and microbiota. Dysfunction or deficiency in these populations leads directly to intestinal inflammation such as colitis and contributes significantly to diseases like inflammatory bowel disease.[1][2][3][4]

Other names
Intestinal regulatory T cellGut-resident regulatory T lymphocyteFoxp3+ regulatory T cell (intestinal)Intestinal TregSuppressor T lymphocyte (historical)
02

Biological functions

Immune response regulationMaintenance of immune tolerance to dietary antigens and commensal microbiotaSuppression of effector T cells and pro-inflammatory responsesSecretion of anti-inflammatory cytokines such as IL‑10Promotion of tissue repair and epithelial barrier integrity in the gut
03

Disease associations

Inflammation (especially intestinal inflammation/IBD)InfectionAutoimmunity/allergy prevention (e.g., food allergy)Loss or dysfunction leads to colitis, IBD, other immunopathologies

Beyond the preview

Go deeper on Regulatory T lymphocyte cell population in intestine (Treg cell (intestinal), Foxp3+ Treg cell).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regulatory T lymphocyte cell population in intestine (Treg cell (intestinal), Foxp3+ Treg cell).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call